Impact Stories

Early Pipeline and Value Assessment

“Are we investing in the right assets – and ready to articulate why they matter?”

Pre-Launch Readiness and Health Technology Assessment

“How do we build a credible, compelling case for value – navigating speed to access, complexity, evidence and engagement gaps?”

Real-World Evidence and Outcome Optimisation

“Can we prove real impact – beyond the clinical trial – in real-world care settings?”

Pricing and Value Strategy

“Is our pricing grounded in value – and ready to stand up to scrutiny?”

Global-to-Local Modelling and Value Assessment

“How do we transform and innovate cost-effectiveness modelling to reflect value and user needs across different systems – and settings?”

Can we prove value for therapies that prevent future harm – not just treat it?

What do patients and clinicians really need from the next generation of IBD therapies?

Can we differentiate in a crowded market – and still deliver first-in-class access?

How do we cut through complexity to drive access in crowded therapeutic areas?